Man Group plc - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Man Group plc ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,355,489
-68.9%
35,484
-70.6%
0.00%
-69.2%
Q2 2023$4,360,249
+1308.5%
120,883
+1391.3%
0.01%
+1200.0%
Q1 2023$309,568
-92.5%
8,106
-91.6%
0.00%
-94.4%
Q4 2020$4,118,000
-51.2%
96,415
-70.0%
0.02%
-45.5%
Q3 2020$8,434,000
+162.8%
320,946
+168.1%
0.03%
+106.2%
Q2 2020$3,209,000
+113.2%
119,693
+43.0%
0.02%
+60.0%
Q1 2020$1,505,000
-81.7%
83,683
-82.0%
0.01%
-63.0%
Q4 2019$8,246,000
-26.9%
465,054
-36.1%
0.03%
-35.7%
Q3 2019$11,287,000
+10.8%
727,733
+22.7%
0.04%
+13.5%
Q2 2019$10,188,000
-18.3%
593,058
-23.4%
0.04%
-21.3%
Q1 2019$12,471,000
-34.3%
774,578
-40.3%
0.05%
-44.0%
Q4 2018$18,982,000
-11.3%
1,297,446
+10.1%
0.08%
+7.7%
Q3 2018$21,405,000
+85.3%
1,178,052
+72.1%
0.08%
+62.5%
Q2 2018$11,549,000
+89.7%
684,603
+120.3%
0.05%
+71.4%
Q1 2018$6,089,000310,7980.03%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders